EUVIMEDEUVIMED entdecken
Crossref

Evaluation on absorption risks of amentoflavone after oral administration in rats

Hui Qiu iD, Zhengbing Guo, Qian Xu, Shengfang Mao, Wenming Wu

Biopharmaceutics & Drug Disposition · 2021-11 · 42 (9) · 435-443

DOI: 10.1002/bdd.2304 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biopharmaceutics & Drug Disposition, online erschienen am 23.10.2021. Verfasst von Hui Qiu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, Nanchang Hongdu Hospital of Traditional Chinese Medicine, Nanchang, Jiangxi, China. Hauptthemen laut MEDLINE: Biflavonoids. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 21 Literaturangaben. Gefördert von: the Science and Technology Plan Projects of Jiangxi Administration of Traditional Chinese Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The present study was aimed to systemically assess the absorption risks of amentoflavone (AMF). Physicochemical properties of AMF were evaluated using in vitro assays including water solubility and stability in both simulated gastric and intestinal fluids, as well as logD, pka and permeability studies in a monolayer Caco‐2 model. The results together suggested that AMF was a compound with moderate intestinal absorption and the poor solubility was the key rate‐limiting step for the oral absorption of AMF, and PVP‐K30 were thus used as a solubilizer to improve its solubility and oral bioavailability. Furthermore, studies on pharmacokinetics and biliary excretion of AMF with tween 80 or PVP‐K30 were performed after oral administration, and the results showed that the percentage of AMF conjugates in bile was determined up to be 96.73% and no AMF conjugates were detected in rat plasma. The above results revealed that the poor oral absorption of AMF may probably be attributed to the low solubility, high level of metabolism and hepatic first‐pass effects. The relative bioavailability of AMF solubilized by PVP‐K30 was about 2‐fold than that of AMF suspended in 1% tween 80. The present study may help provide scientific insights to guide the rational design of AMF into more efficient formulation systems.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiflavonoidsAdministration, OralAnimalsBiological AvailabilityCaco-2 CellsHumansIntestinal AbsorptionRatsSolubility

Stichwörter der Autor:innen

amentoflavonebiliary excretionhepatic first-pass effectspermeability studiesphysicochemical properties

Substanzen

Biflavonoidsamentoflavone

Autor:innen und Institutionen

  • Department of Pharmaceutics, Nanchang Hongdu Hospital of Traditional Chinese Medicine, Nanchang, Jiangxi, China.
  • Jiangxi Provincial People's Hospital, Nanchang, Jiangxi, China.

ORCID-Profile: Hui Qiu

Förderung

  • the Science and Technology Plan Projects of Jiangxi Administration of Traditional Chinese Medicine

Zitieren

APA

Qiu, H., Guo, Z., Xu, Q., Mao, S., & Wu, W. (2021). Evaluation on absorption risks of amentoflavone after oral administration in rats. Biopharmaceutics & Drug Disposition, 42(9), 435-443. https://doi.org/10.1002/bdd.2304

Vancouver

Qiu H, Guo Z, Xu Q, Mao S, Wu W. Evaluation on absorption risks of amentoflavone after oral administration in rats. Biopharmaceutics & Drug Disposition. 2021;42(9):435-443. doi:10.1002/bdd.2304

BibTeX
@article{Qiu2021,
  author = {Qiu, Hui and Guo, Zhengbing and Xu, Qian and Mao, Shengfang and Wu, Wenming},
  title = {Evaluation on absorption risks of amentoflavone after oral administration in rats},
  journal = {Biopharmaceutics & Drug Disposition},
  year = {2021},
  volume = {42},
  number = {9},
  pages = {435--443},
  doi = {10.1002/bdd.2304}
}
Kostenlos starten →